LOS ANGELES--(BUSINESS WIRE)--C3 Jian, Inc.’s Board of Directors today announced that the Company has signed an agreement with the West China School of Stomatology at Sichuan University (“West China”) to create a joint Clinical Research Centre (CRC) to test new oral healthcare products in human clinical trials. The C3 Jian/West China CRC will be located in West China’s facilities in Chengdu, China. C3 Jian’s wholly owned subsidiary, Sen Nuo Wei Biotechnology Co, Ltd., based in Chengdu, was also a party to the agreement. The newly created CRC will be a strategically important site for C3 Jian as it moves its products from research to clinical development. West China, the first and largest dental university in China, has agreed to develop and operate the CRC under U.S. Food and Drug Administration Good Clinical Practices (GCP).
